The re-infection rate of high-risk HPV and the recurrence rate of vulvar intraepithelial neoplasia (VIN) usual type after surgical treatment

Medical Science Monitor

Volumn 17, Issue 9, 2011, Pages

  Frega, Antonio ^a   Sopracordevole, Francesco ^b   Scirpa, Paolo ^c   Biamonti, Alberto ^d   Lorenzon, Laura ^e   Scarani, Simona ^a   de Sanctis, Luana ^a   Pacchiarotti, Arianna ^a   Moscarini, Massimo ^a   French, Deborah ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^c CATHOLIC UNIVERSITY   (Italy)

^d Cristo Re Hospital   (Italy)

^e SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

HPV DNA test; Human papillomavirus (HPV); VIN usual type

Indexed keywords

ADULT; ARTICLE; CARBON DIOXIDE LASER; EXCISION; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OUTCOME ASSESSMENT; PAPILLOMAVIRUS INFECTION; PROSPECTIVE STUDY; RECURRENT DISEASE; REINFECTION; REOPERATION; VAGINAL INTRAEPITHELIAL NEOPLASIA;

EID: 80054010183     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/MSM.881941     Document Type: Article

References (26)

1. Sideri M, Jones RW, Wilkinson EJ et al: Squamous vulvar intraepithe-lial neoplasia: 2004 modifed terminology, ISSVD Vulvar Oncology Subcommittee. J Reprod Med, 2005; 50(11): 807-10
2. De Vuyst H, Clifford GM, Nascimento MC et al: Prevalence and type distribution of human papillomavirus in carcinoma and intraepitheli-al neoplasia of the vulva, vagina and anus: A meta-analysis. Int J Cancer, 2009; 124(7): 1626-36
3. Lacey CJ, Lowndes CM, Shah KV: Chapter 4: Burden and management of non-cancerous HPV-related conditions: HPV-6/11 disease. Vaccine, 2006; 24(Suppl.3): S3/35-41
4. Fonseca-Moutinho JA: Vulvar intraepithelial neoplasia: a current problem. Rev Bras Ginecol Obstet, 2008; 30(8): 420-26
5. Junge J, Poulsen H, Horn T et al: Prognosis of vulvar dysplasia and carcinoma in situ with special reference to histology and types of human papillomavirus (HPV). APMIS, 1997; 105(12): 963-71
6. Jones RW: Vulval intraepithelial neoplasia: current perspectives. Eur J Gynaecol Oncol, 2001; 22(6): 393-402
7. Kirwan JM, and Herod JJO: Premalignant vulvar disorders. Current Obstetrics & Gynaecology, 2002; 12: 90-96
8. Winters U, Daayana S, Lear JT et al: Clinical and immunologic results of a phase II trial of sequential imiquimod and photodynamic therapy for vulval intraepithelial neoplasia. Clin Cancer Res, 2008; 14(16): 5292-99
9. Lai KW, Mercurio MG: Medical and surgical approaches to vulvar in-traepithelial neoplasia. Dermatol Ther, 2010; 23(5): 477-84
10. Herod JJ, Shaf MI, Rollason TP et al: Vulvar intraepithelial neopla-sia: long term follow up of treated and untreated women. Br J Obstet Gynaecol, 1996; 103(5): 446-52
11. Korn AP, Abercrombie PD, Foster A: Vulvar intraepithelial neoplasia in women infected with human immunodefciency virus-1. Gynecol Oncol, 1996; 61(3): 384-86
12. Jones RW, Rowan DM, Stewart AW: Vulvar intraepithelial neoplasia: aspects of the natural history and outcome in 405 women. Obstet Gynecol, 2005; 106(6): 1319-26
13. Küppers V, Stiller M, Somville T, Bender HG: Risk factors for recurrent VIN: role of multifocality and grade of disease. J Reprod Med, 1997; 42(3): 140-44
14. Ahr A, Rody A, Kissler S et al: Risk factors for recurrence of vulvar intraep-ithelial neoplasia III (VIN III). Zentralbl Gynakol, 2006; 128(6): 347-51
15. Hillemanns P, Wang X, Staehle S et al: Evaluation of different treatment modalities for vulvar intraepithelial neoplasia (VIN): CO(2) laser vaporization, photodynamic therapy, excision and vulvectomy. Gynecol Oncol, 2006; 100(2): 271-75
16. Garland SM, Insinga R P, Sings HL et al: Human Papillomavirus Infections and Vulvar Disease Development. Cancer Epidemiol Biomarkers Prev, 2009; 18(6): 1777-84
17. Penna C, Fallani MG, Fambrini M et al: CO2 laser surgery for vulvar intraepithelial neoplasia. Excisional, destructive and combined techniques. J Reprod Med, 2002; 47(11): 913-18
18. Houffin Debarge V, Collinet P, Vinatier D et al: Value of human pap-illomavirus testing after conization by loop electrosurgical excision for high-grade squamous intraepithelial lesions. Gynecol Oncol, 2003; 90(3): 587-92
19. Kim YT, Lee JM, Hur SY et al: Clearance of human papillomavirus infection after successful conization in patients with cervical intraepithe-lial neoplasia. Int J Cancer, 2009; 126(8): 1903-9
20. Nam K, Chung S, Kim J et al: Factors associated with HPV persistence after conization in patients with negative margins. J Gynecol Oncol, 2009; 20(2): 91-95
21. Winer RL, Kiviat NB, Hughes JP et al: Development and duration of human papillomavirus lesions, after initial infection. J Infect Dis, 2005; 191(5): 731-38
22. Rufforny I, Wilkinson EJ, Liu C et al: Human papillomavirus infection and p16(INK4a) protein expression in vulvar intraepithelial neopla-sia and invasive squamous cell carcinoma. J Low Genit Tract Dis, 2005; 9(2): 108-13
23. Hillemanns P, Wang X: Integration of HPV-16 and HPV-18 DNA in vul-var intraepithelial neoplasia. Gynecol Oncol, 2006; 100(2): 276-82
24. Gasco M, Sullivan A, Repellin C et al: Coincident inactivation of 14-3-3sigma and p16INK4a is an early event in vulvar squamous neo-plasia. Oncogene, 2002; 21(12): 1876-81
25. Logani S, Lu D, Quint WG et al: Low-grade vulvar and vaginal intraep-ithelial neoplasia: correlation of histologic features with human pap-illomavirus DNA detection and MIB-1 immunostaining. Mod Pathol, 2003; 16(8): 735-41
26. Skapa P, Zamecnik J, Hamsikova E et al: Human papillomavirus (HPV) profles of vulvar lesions: possible implications for the classifcation of vulvar squamous cell carcinoma precursors and for the effcacy of prophylactic HPV vaccination. Am J Surg Pathol, 2007; 31(12): 1834-43